Bio-Rad Laboratories, Inc.
(NYSE : BIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DXCMDexCom, Inc. 0.85%381.548.2%$1043.16m
ABTAbbott Laboratories -1.61%93.390.8%$670.29m
BDXBecton, Dickinson & Co. -0.09%246.711.0%$634.71m
DHRDanaher Corp. -0.52%165.750.7%$592.91m
MDTMedtronic Plc -0.33%98.260.6%$549.92m
TMOThermo Fisher Scientific, Inc. 0.29%350.211.0%$509.00m
INOInovio Pharmaceuticals, Inc. 0.68%14.856.3%$442.95m
BSXBoston Scientific Corp. -1.03%37.601.1%$405.21m
ISRGIntuitive Surgical, Inc. -0.65%576.282.4%$367.81m
SYKStryker Corp. 1.17%198.011.3%$366.99m
WSTWest Pharmaceutical Services, Inc. -1.06%213.761.6%$302.91m
ALGNAlign Technology, Inc. 1.74%249.896.4%$301.94m
BAXBaxter International, Inc. 0.79%90.721.8%$264.98m
QDELQuidel Corp. 0.43%175.767.7%$218.00m
MASIMasimo Corp. -0.92%237.975.2%$197.62m

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.